Company Filing History:
Years Active: 2020-2022
Title: Innovations by Claudio Zihlmann
Introduction
Claudio Zihlmann is a notable inventor based in Lucerne, Switzerland. He has made significant contributions to the field of biomedical materials, particularly in the development of bone substitute materials. With a total of five patents to his name, Zihlmann's work is recognized for its innovative approaches to enhancing bone regeneration and repair.
Latest Patents
Zihlmann's latest patents include a collagen matrix or granulate blend of bone substitute material. This invention involves a collagen matrix granulate blend that includes collagen and particles of a biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material. The process for making and using this blend features a sintered CAP core covered by a closed epitactically grown layer of nanocrystalline HAP. This layer is designed to mimic the size and morphology of human bone mineral, enhancing its compatibility and effectiveness in medical applications. Another patent focuses on a biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material that promotes bone formation and regeneration through its unique structural properties.
Career Highlights
Claudio Zihlmann is currently associated with Geistlich Pharma AG, a company renowned for its advancements in regenerative medicine. His work at Geistlich Pharma AG has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in bone substitute materials.
Collaborations
Zihlmann has worked closely with Michael Alexander Bufler, a fellow innovator in the field. Their collaboration has led to the development of advanced materials that are crucial for improving patient outcomes in bone repair and regeneration.
Conclusion
Claudio Zihlmann's innovative contributions to the field of biomedical materials, particularly in bone substitute technology, highlight his role as a leading inventor. His patents reflect a commitment to enhancing medical treatments and improving the quality of life for patients.